Testimonials
The election is over, and with it also comes the end (for now) of the seemingly endless text messages, mail, dinnertime phone calls, and TV and social media ads. But there are many questions as to what comes next and not a lot of answers just yet. Listen to "Unscripted" The AMCP Podcast, for updates from the new Trump administration and Congress's health policy agenda from AMCP.
AMCP 2024 AAO Report
AMCP's feature annual report explores how professionals in managed care pharmacy work diligently to facilitate appropriate access to prescription treatments while remaining mindful of rising costs. It discusses key areas of focus such as pharmacy benefit design, formulary management, clinical programs, quality, safety and promoting affordability of medicines.
AMCP eModel is the ultimate tool for communication of health economic models and value evidence. Find out more about this tech partnership and this health economic modeling platform to support the exchange of clinical and economic information between manufacturers and payers.
AMCP partners with FormularyDecisions to enhance information sharing and formulary decision-making by creating a platform for current, credible, and compliant information exchange between life science companies and active, qualified healthcare decision-makers.
Featured
-
Health Information Technology Resources
-
Digital Therapeutics Resources
-
Health Disparities Resources
-
Value-Based Contracts Resources
Meetings Proceedings & Findings
View More
Latest News & Resources
Sponsored webinar that educated payers on the important features of axial spondyloarthritis (axSpA) to help with early detection.
Sponsored webinar that discussed advances in continuous glucose monitoring (CGM) technology.
Sponsored webinar that discussed advances in continuous glucose monitoring (CGM) technology.
Sponsored webinar that provided an overview of insomnia disorder and the current challenges in adequately treating patients.
AMCP webinar that reviewed a summary of discussions from this summit.
AMCP webinar that reviewed a summary of discussions from this summit.
AMCP CEO Blog: With PA so often misunderstood, perhaps we need to do a better job of explaining this tool to the general public. For example, we might provide an example of how PAs are applied to opioids as additional safeguards to ensure their appropriate use. Or how a PA might be applied to botulinum toxin to ensure the prescription is for medical, rather than cosmetic, purposes.
From the AMCP Policy Digest, AMCP's policies regarding health information and automation technology.
From the AMCP Policy Digest, AMCP's policies regarding workforce issues.
From the AMCP Policy Digest, AMCP's policies regarding drug integrity issues.
From the AMCP Policy Digest, AMCP's policies regarding pharmacy practice issues.
From the AMCP Policy Digest, AMCP's policies regarding managed care pharmacy tools.
